NYULangone

New York, New York 11355

25 studies enrolling now · 90 studies all time

What they study most

ACL Injury, Acute Gastrointestinal Bleeding, Acute Gout Flare, Advanced Breast Cancer, Advanced Cancer, Advanced Solid Tumor, Advanced Solid Tumor, Adult, Advanced Solid Tumors, Anesthesia, Anesthesia Awareness, Anesthesia Complication, Anesthesia Morbidity

Studies at this site

• Shield Post-Approval Study Protocol — Recruiting now
• Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study) — Recruiting now
• A Study of ARC-02 in B-cell NHL — Recruiting now
• A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD) — Recruiting now
• A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• Smartphones for Opiate Addiction Recovery — Recruiting now
• Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding — Recruiting now
• The Effect of Yoga Practice on Chronic Back Pain — Recruiting now
• Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors — Recruiting now
• EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND) — Recruiting now
• Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
• Daratumumab in Primary Antiphospholipid Syndrome — Recruiting now
• Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease — Recruiting now
• XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP) — Recruiting now
• Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare — Recruiting now
• EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures — Recruiting now
• Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors — Recruiting now
• A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors — Recruiting now
• A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity — Recruiting now
• EFS of the CardioMech MVRS — Recruiting now
• Helmsley 3.0: Abbreviated MRE — Recruiting now
• Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout — Recruiting now
• First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer — Recruiting now
• Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial — Recruiting now
• GEN1046 Safety Trial in Patients With Malignant Solid Tumors — Running, not enrolling
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease — Running, not enrolling
• AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion — Running, not enrolling
• A Study of Baricitinib in Participants With Rheumatoid Arthritis — Completed
• MOTUS Total Joint Replacement Investigational Device Exemption Study — Running, not enrolling
• Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) — Running, not enrolling
• Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD — Running, not enrolling
• Assessment of Combined CCM and ICD Device in HFrEF — Running, not enrolling
• Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC — Running, not enrolling
• Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder — Available (expanded access)
• Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) — Running, not enrolling
• A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors — Running, not enrolling
• Electrical Stimulation for the Treatment of Glaucoma — Running, not enrolling
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) — Running, not enrolling
• Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] — Completed
• Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors — Running, not enrolling
• Postoperative Immobilization and Physical Therapy Following Volar Locked Plating for Distal Radius Fractures — Running, not enrolling
• A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus — Completed
• Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide — Running, not enrolling
• Expanded Access Program for OOS Obe-cel — Available (expanded access)
• Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial — Running, not enrolling
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed
• Diffusion MRI for Head and Neck Cancer — Running, not enrolling
• The PROTEMBO Trial — Completed
• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) — Running, not enrolling
• The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC — Completed